Brainstorm Cell Therapeutics (BCLI) Accumulated Expenses (2010 - 2026)
Brainstorm Cell Therapeutics' Accumulated Expenses was $454,000 in Q2 2026, up 23.7% from $367,000 a year earlier and up 9.7% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Brainstorm Cell Therapeutics came in at $396,000, down 36.0% from FY2024.
- Accumulated Expenses shows a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- In earlier years, Accumulated Expenses was $619,000 in FY2024 (-50.1%), $1.24 million in FY2023, $84,000 in FY2022 (+1.2%) and $83,000 in FY2021 (-93.4%).
- The Q2 2026 figure marks the highest quarterly Accumulated Expenses since Q1 2025.
- Compared with a year earlier, Accumulated Expenses was higher in 1 of the last seven quarters, with an average decline of 29.9%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q2 2024 (growth of 697.8%); the worst was Q2 2022 (a decline of 97.4%).
- Per Business Quant data, BCLI's Accumulated Expenses in the three quarters before Q2 2026 was $414,000 (Q1 2026), $396,000 (Q4 2025) and $350,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.23 Bn | 1,139.82 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 648.76 Bn | 568.62 Bn | 17.30 Bn |
| 3 | AbbVie | 503.78 Bn | 476.89 Bn | 12.70 Bn |
| 4 | Merck | 366.20 Bn | 320.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.55 Bn | 267.54 Bn | 11.24 Bn |
| 6 | Astrazeneca | 269.42 Bn | 243.11 Bn | 12.86 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn |
| 9 | Pfizer | 172.42 Bn | 119.07 Bn | 10.94 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 454,000.00 |
| Mar 31, 2026 | 414,000.00 |
| Dec 31, 2025 | 396,000.00 |
| Sep 30, 2025 | 350,000.00 |
| Jun 30, 2025 | 367,000.00 |
| Mar 31, 2025 | 538,000.00 |
| Dec 31, 2024 | 619,000.00 |
| Sep 30, 2024 | 865,000.00 |
| Jun 30, 2024 | 718,000.00 |
| Mar 31, 2024 | 636,000.00 |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 63,000.00 |
| Jun 30, 2023 | 90,000.00 |
| Mar 31, 2023 | 171,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 58,000.00 |
| Jun 30, 2022 | 44,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Dec 31, 2021 | 83,000.00 |
| Sep 30, 2021 | 387,000.00 |
API Access
Brainstorm Cell Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();